COVID-19: 90-Day Refills May Strain Supply Chain – Specialty Pharmacy Continuum

According to the article:

“Across the country, pharmacies have been seeing a significant uptick in patients seeking to extend 30-day prescriptions to 90 days to ensure access to their medications amid the growing COVID-19 crisis. While stakeholders say they have been able to meet these requests, several indicate that it’s only a matter of time before the supply chain buckles under these new pressures.”

Read the source article:  COVID-19: 90-Day Refills May Strain Supply Chain – Specialty Pharmacy Continuum


Go to DREprof.com: The Designated Representative and Exemptee Training Website

Mediledger completes FDA blockchain pilot with 7 of top 10 pharma firms – Ledger Insights

According to the article:

“Blockchain startup Mediledger has published the results of its FDA blockchain pilot for the pharmaceutical supply chain. Numerous separate groups applied to the FDA and ran pilots for the Drug Supply Chain Security Act (DSCSA) 2023 milestone for package-level tracing, with this being one of the largest groups. Mediledger’s participants included all three major U.S. wholesalers, seven out of ten of the world’s largest pharmaceutical companies, massive dispensers Walgreens and Walmart, as well as logistics firms such as FedEx.”

Read the source article:  Mediledger completes FDA blockchain pilot with 7 of top 10 pharma firms – Ledger Insights


Go to DREprof.com: The Designated Representative and Exemptee Training Website

Coronavirus and the Automotive and Pharmaceutical Supply Chains – Logistics Viewpoint

According to the article:

Another industry that is feeling the impact of the coronavirus is the pharmaceutical industry. The average buffer inventory for the pharmaceutical industry is between three and six months. However, this does not tell the full story. Gaurav mentioned that China is responsible for producing 40 percent of the active pharmaceutical ingredients (APIs) for the pharmaceutical world. Additionally, China supplies 80 percent of key starting materials (KSM’s), which are the chemicals in APIs, to India. Put together, this represents 70 percent of all APIs across the world.

Read the source article:  Coronavirus and the Automotive and Pharmaceutical Supply Chains – Logistics Viewpoint


Go to DREprof.com: The Designated Representative and Exemptee Training Website

HDA board passes leadership to AAM’s Chip Davis – Pharmaceutical Commerce

According to the article:

“After a search, the board of directors at the Healthcare Distribution Alliance has chosen Chester “Chip” Davis to be president and CEO. John Gray, HDA CEO since 2004, announced his retirement last year; Davis will take over next month. Davis comes to HDA from president and CEO of the Assn. for Accessible Medicines (the former Generic Pharmaceuticals Assn.), which appointed him in 2015. Formerly, he was EVP for advocacy at the Pharmaceutical Research and Manufacturers of America.”

Read the full source article: HDA board passes leadership to AAM’s Chip Davis – Pharmaceutical Commerce


Go to DREprof.com: The Designated Representative and Exemptee Training Website